RecruitingPhase 1NCT05241262
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
Studying Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Michio Hirano, MD
- Principal Investigator
- Michio Hirano, MDColumbia University
- Intervention
- N-Acetylcysteine(drug)
- Enrollment
- 18 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Columbia University Irving Medical Center, New York, New York, United States
Collaborators
United States Department of Defense
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05241262 on ClinicalTrials.govOther trials for Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes
Additional recruiting or active studies for the same condition.